BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36137311)

  • 1. Allyl phenyl selenides as H
    Yang XY; Yuan B; Xiong H; Zhao Y; Wang L; Zhang SQ; Mao S
    Bioorg Chem; 2022 Dec; 129():106154. PubMed ID: 36137311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
    Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
    Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
    [No Abstract]   [Full Text] [Related]  

  • 3. A Smart Theranostic Prodrug System Activated by Reactive Oxygen Species for Regional Chemotherapy of Metastatic Cancer.
    Liu L; Liu F; Liu D; Yuan W; Zhang M; Wei P; Yi T
    Angew Chem Int Ed Engl; 2022 Mar; 61(12):e202116807. PubMed ID: 35068033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy.
    Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z
    J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An activatable prodrug for the treatment of metastatic tumors.
    Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
    J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases.
    Wang P; Gong Q; Hu J; Li X; Zhang X
    J Med Chem; 2021 Jan; 64(1):298-325. PubMed ID: 33356214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy.
    Zhang J; Sun X; Xu M; Zhao X; Yang C; Li K; Zhao F; Hu H; Qiao M; Chen D; Zhao X
    Acta Biomater; 2022 Sep; 149():307-320. PubMed ID: 35764242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
    Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
    Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecin.
    Gong X; Wang Z; Zhang L; Dong W; Wang R; Liu Y; Song S; Hu Q; Du F; Shuang S; Dong C
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112712. PubMed ID: 35921692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric Nanoparticles with ROS-Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer.
    Hao Y; Chen Y; He X; Yu Y; Han R; Li Y; Yang C; Hu D; Qian Z
    Adv Sci (Weinh); 2020 Oct; 7(20):2001853. PubMed ID: 33101874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/Chemotherapy.
    Li J; Li Y; Wang Y; Ke W; Chen W; Wang W; Ge Z
    Nano Lett; 2017 Nov; 17(11):6983-6990. PubMed ID: 28977746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
    Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
    Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety.
    Zhu J; Chen J; Song D; Zhang W; Guo J; Cai G; Ren Y; Wan C; Kong L; Yu W
    J Mater Chem B; 2019 Dec; 7(47):7548-7557. PubMed ID: 31720667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.
    Luo X; Chi X; Lin Y; Yang Z; Lin H; Gao J
    Chem Commun (Camb); 2021 Oct; 57(84):11033-11036. PubMed ID: 34608474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.
    Liu P; Xu J; Yan D; Zhang P; Zeng F; Li B; Wu S
    Chem Commun (Camb); 2015 Jun; 51(46):9567-70. PubMed ID: 25971544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
    Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
    Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
    Wang L; Xie S; Ma L; Chen Y; Lu W
    Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
    Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
    Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
    Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
    Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.